SPRY icon

ARS Pharmaceuticals

70 hedge funds and large institutions have $94.7M invested in ARS Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

less ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

25% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 28

53% less capital invested

Capital invested by funds: $200M → $94.7M (-$106M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
70
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$188K
Puts
$3K
Net Calls
Net Calls Change

Top Buyers

1 +$4.21M
2 +$1.06M
3 +$953K
4
Bank of America
Bank of America
North Carolina
+$843K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$506K

Top Sellers

1 -$11.6M
2 -$3.96M
3 -$3.53M
4
EC
EcoR1 Capital
California
-$2.56M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.71M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$30.7M
2
$13.3M
3
$10.4M
4
$6.7M
5
$5.64M
6
$3.15M
7
$2.89M
8
$2.35M
9
$1.41M
10
$1.35M
11
$1.3M
12
$1.27M
13
$1.22M
14
$1.21M
15
$1.16M
16
$1.14M
17
$1.05M
18
$926K
19
$685K
20
$658K
21
$609K
22
$534K
23
$518K
24
$398K
25
$360K